-
July 13, 2021 Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat AddictionAnthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that...
-
June 22, 2021 How The Multidisciplinary Association for Psychedelic Studies Is Changing Mental Health TreatmentThe Multidisciplinary Association for Psychedelic Studies has been studying mental health treatment for more than...
-
May 4, 2021 Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSDThe first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.
-
April 6, 2021 Study Investigates Optimal Dosing for MDMAPotential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a...
-
March 16, 2021 U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for AddictionAwakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol...
-
March 9, 2021 Minority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic TherapiesA minority veterans organization wants access to psychedelic therapies for PTSD and depression. It's urging...
-
February 17, 2021 Charley Wininger Hopes to Normalize MDMA With New Book ‘Listening to Ecstasy’In his book 'Listening to Ecstasy' psychoanalyst and mental health counselor Charley Wininger discusses MDMA's...
